Allo Transplantation With Mylotarg, Fludarabine and Melphalan for AML, CML and MDS

NCT00038831 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

47

Enrollment

OTHER

Sponsor class

Conditions

Acute Myelogenous Leukemia
Myelodysplastic Syndrome
Chronic Lymphocytic Leukemia

Interventions

DRUG: Mylotarg
DRUG: Fludarabine
DRUG: Melphalan
DRUG: Anti-thymocyte globulin
PROCEDURE: Stem cell transplant

Sponsor

M.D. Anderson Cancer Center